X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (364) 364
Publication (64) 64
Book Chapter (9) 9
Book Review (7) 7
Dissertation (5) 5
Newspaper Article (5) 5
Book / eBook (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (167) 167
humans (166) 166
oncology (161) 161
female (91) 91
male (88) 88
lung neoplasms - drug therapy (76) 76
aged (75) 75
carcinoma, non-small-cell lung - drug therapy (71) 71
middle aged (70) 70
immunotherapy (67) 67
cancer (66) 66
chemotherapy (62) 62
lung cancer (60) 60
adult (56) 56
article (52) 52
lung neoplasms - pathology (48) 48
antineoplastic agents - therapeutic use (42) 42
antineoplastic combined chemotherapy protocols - therapeutic use (42) 42
carcinoma, non-small-cell lung - pathology (39) 39
neoplasm staging (38) 38
nivolumab (38) 38
care and treatment (37) 37
aged, 80 and over (35) 35
treatment outcome (34) 34
lung cancer, non-small cell (33) 33
tumors (33) 33
docetaxel (32) 32
patients (32) 32
antibodies, monoclonal - therapeutic use (31) 31
bevacizumab (30) 30
respiratory system (30) 30
ipilimumab (29) 29
survival (29) 29
melanoma (28) 28
research (28) 28
safety (28) 28
lung neoplasms - mortality (25) 25
mutation (25) 25
open-label (25) 25
drug therapy (24) 24
analysis (23) 23
animals (23) 23
cell lung-cancer (23) 23
lung neoplasms - genetics (23) 23
apoptosis (22) 22
carcinoma, non-small-cell lung - mortality (22) 22
carcinoma, non-small-cell lung - genetics (21) 21
cancer therapies (20) 20
clinical trials (20) 20
metastasis (20) 20
neoplasms - drug therapy (20) 20
non-small cell lung cancer (20) 20
therapy (20) 20
abridged index medicus (19) 19
antibodies, monoclonal - administration & dosage (19) 19
disease-free survival (19) 19
lung neoplasms - immunology (19) 19
prognosis (19) 19
survival rate (19) 19
carboplatin (18) 18
lung neoplasms - therapy (18) 18
medicine & public health (18) 18
pembrolizumab (18) 18
antineoplastic agents - adverse effects (17) 17
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
immunotherapy - methods (17) 17
trial (17) 17
antibodies, monoclonal - adverse effects (16) 16
erlotinib (16) 16
expression (16) 16
hematology, oncology and palliative medicine (16) 16
lymphocytes (16) 16
mutations (16) 16
non-small cell lung carcinoma (16) 16
pd-1 (16) 16
solid tumors (16) 16
antibody (15) 15
medical research (15) 15
medicine, general & internal (15) 15
paclitaxel (15) 15
pd-l1 protein (15) 15
antibodies, monoclonal, humanized (14) 14
carcinoma (14) 14
carcinoma, non-small-cell lung - therapy (14) 14
gefitinib (14) 14
gemcitabine (14) 14
immunology (14) 14
mice (14) 14
paclitaxel - administration & dosage (14) 14
pd-l1 (14) 14
programmed cell death 1 receptor - antagonists & inhibitors (14) 14
blockade (13) 13
carcinoma, non-small-cell lung - immunology (13) 13
dosage and administration (13) 13
health aspects (13) 13
retrospective studies (13) 13
antibodies, monoclonal - pharmacology (12) 12
antigens (12) 12
biomarkers (12) 12
carboplatin - administration & dosage (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 17, pp. 1627 - 1639
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2013, Volume 31, Issue 8, pp. 1021 - 1028
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2019, Volume 81, p. 37
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 21, pp. 1976 - 1986
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1823 - 1833
Journal Article
2007, 1, Translational medicine series, ISBN 9780849390210, Volume 3, viii, 265
Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap in the literature, this resource translates recent laboratory... 
Chemotherapy | Treatment | drug therapy | Lungs | Antineoplastic Agents | Technological innovations | Lung Neoplasms | Molecular aspects | therapeutic use | Cancer | Oncology | Pulmonary Medicine | Lungs - Cancer - Molecular aspects
Book
Clinical Cancer Research, ISSN 1078-0432, 10/2014, Volume 20, Issue 19, pp. 5064 - 5074
Journal Article
Seminars in Oncology, ISSN 0093-7754, 02/2014, Volume 41, Issue 1, pp. 126 - 132
Over the past 20 years, immunotherapy has not played a role in the treatment of lung cancer outside of clinical trials. Early trials with vaccines yielded... 
CARBOPLATIN | ONCOLOGY | SAFETY | REGULATORY T-CELLS | DOUBLE-BLIND | CTLA-4 | ANTITUMOR IMMUNITY | COMBINATION | EXPRESSION | IPILIMUMAB | PACLITAXEL | Lung Neoplasms - drug therapy | Cancer Vaccines - therapeutic use | Lung Neoplasms - immunology | Animals | Humans | Immunotherapy | Antibodies, Monoclonal - therapeutic use
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 22, pp. 2093 - 2104
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 2, pp. 123 - 135
Journal Article